ResearcherStanford UniversityNo recent work listed

Zhentian Wang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2020: 1 paper

Papers 1

SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Co-author DOI 10.1016/j.ccell.2020.04.014 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huamin Wang · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Julien Sage · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Pawel Karol Mazur · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Michael P. Kim · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Anirban Maitra · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Or P. Gozani · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗
Simone Hausmann · 1 shared paper, 2020 · strength 0.08
- Paper SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. DOI 10.1016/j.ccell.2020.04.014 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.